Sh Jagmohan Tyagi GSTO

## Policy Analysis Report: Delhi Goods and Services Tax Act, 2017 - NotificationAEIDTT20212214 **1. Executive Summary:** This report analyzes NotificationAEIDTT20212214 issued by the Government of the National Capital Territory of Delhi on December 21, 2021, pertaining to the Delhi Goods and Services Tax (DGST) Act, 2017. The notification concerns the conferment of powers under specific sections of the DGST Act, 2017, to designated Proper Officers in relation to specified taxpayers. This notification temporarily reassigns authority for certain actions regarding a specific taxpayer. The key finding is that the powers under sections 69, 70, 71, 73 and 74 of the DGST Act, 2017, are conferred to Sh. Jagmohan Tyagi, GSTO with respect to Ms Bharat Pharma (GSTIN: 07ABWPB1401F1Z3) for a period of 120 days. **2. Introduction:** This report aims to provide an informative overview and analysis of NotificationAEIDTT20212214 concerning the Delhi Goods and Services Tax (DGST) Act, 2017, as published in the Delhi Gazette. The analysis is based solely on the information provided within the notification text. **3. Policy Overview:** This document is a notification under the Delhi Goods and Services Tax Act, 2017 (DELHI ACT 03 OF 2017). The core objective, as inferred from the provided text, is to delegate/assign specific powers vested under the DGST Act to designated officers. **4. Background and Rationale:** This notification appears to address the need for efficient administration and enforcement of the DGST Act. By conferring powers under specific sections to designated officers, the notification likely aims to streamline processes related to investigation, inspection, assessment, or recovery of taxes from specific taxpayers. This could be due to specific circumstances related to the mentioned taxpayer or for administrative efficiency. **5. Key Provisions / Changes:** This is a new directive which confers the powers from the DGST Act, 2017 to certain officers for the administration of the act with regards to specified Taxpayers. * **Specific Changes:** The core change introduced by this notification is the assignment of powers related to sections 69, 70, 71, 73 and 74 of the Delhi Goods and Services Tax Act, 2017 to Sh. Jagmohan Tyagi, GSTO, for Ms Bharat Pharma (GSTIN: 07ABWPB1401F1Z3). * **New Provision:** The new provision established through this notification is the conferment of powers to this specific officer for this specific taxpayer. The notification stipulates that this conferment is valid for 120 days from the date of issuance or until further orders, whichever is earlier. Further, during this period, the jurisdictional Proper Officer will not be able to exercise those same powers. * **Effect of the Change:** This change effectively shifts the responsibility for actions under sections 69, 70, 71, 73 and 74 of the DGST Act, 2017 concerning Ms Bharat Pharma from the standard jurisdictional officer to Sh. Jagmohan Tyagi, GSTO. This likely indicates a specific need or reason for this temporary reassignment. **6. Target Audience and Stakeholders:** The primary stakeholders directly affected by this notification are: * **Ms Bharat Pharma:** As the taxpayer specifically named in the notification, they will be directly impacted by this reassignment of authority. * **Sh. Jagmohan Tyagi, GSTO:** As the designated officer, he is now responsible for exercising powers under the specified sections of the DGST Act with respect to Ms Bharat Pharma. * **The Jurisdictional Proper Officer:** This officer's authority under sections 69, 70, 71, 73 and 74 of the DGST Act, 2017 with respect to Ms Bharat Pharma is suspended for 120 days. **7. Implementation Aspects (Inferred):** * **Responsible Agency/Bodies:** The Department of Trade and Taxes, Government of the National Capital Territory of Delhi, is the responsible agency. The Commissioner, State Tax, is the issuing authority. * **Timelines:** The notification is effective for 120 days from December 21, 2021, or until further orders. * **Procedures:** The standard procedures under sections 69, 70, 71, 73 and 74 of the DGST Act, 2017, will now be carried out by the designated officer (Sh. Jagmohan Tyagi, GSTO) with respect to the specified taxpayer (Ms Bharat Pharma). **8. Expected Outcomes / Impact of Changes:** The likely intended outcome of this notification is to facilitate a more focused or specialized approach to the administration or enforcement of the DGST Act with respect to Ms Bharat Pharma. The specific reason for this reassignment is not explicitly stated in the text, but it could be related to an ongoing investigation, a specific assessment requirement, or a need for more specialized expertise. The short-term impact is a shift in the point of contact and the officer responsible for these specific sections of the DGST act. **9. Conclusion:** NotificationAEIDTT20212214 represents a specific delegation of powers under the DGST Act, 2017, to a designated officer for a limited time with respect to a specific taxpayer. This reassignment likely aims to improve the efficiency or effectiveness of tax administration or enforcement in this particular case. The notification highlights the dynamic nature of tax administration and the government's ability to tailor its approach to specific situations.

Key Entities Referenced